Li, Shan
Wong, Alicia
Sun, Huiyun
Bhatia, Vipul
Javier, Gerardo
Jana, Sujata http://orcid.org/0000-0003-2718-0307
Wu, Qian
Montgomery, Robert B.
Wright, Jonathan L.
Lam, Hung-Ming
Hsieh, Andrew C. http://orcid.org/0000-0002-0897-1050
Faltas, Bishoy M. http://orcid.org/0000-0002-6432-1693
Haffner, Michael C.
Lee, John K. http://orcid.org/0000-0002-6570-2180
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP2 CA271301, DP2 CA271301)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-19-1-0569, W81XWH-20-1-0083, W81XWH-19-1-0658)
Bladder Cancer Advocacy Network (Research Innovator Award)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA015704, R01 CA276308, R37 CA230617)
University of Washington Don L. Rich Urethral Cancer Research Fund Seattle Translational Tumor Research Program in Bladder Cancer
Prostate Cancer Foundation (Young Investigator Award)
Seattle Translational Tumor Research Program in Bladder Cancer
Article History
Received: 17 April 2023
Accepted: 25 January 2024
First Online: 29 February 2024
Competing interests
: J.K.L. served on the Speaker’s Bureau for Mission Bio. B.M.F. has consulting or advisory roles with QED Therapeutics, Boston Gene, Astrin Biosciences Merck, Immunomedics/Gilead, Guardant and Janssen and receives patent royalties from Immunomedics/Gilead and research support from Eli Lilly. All other authors declare no competing interests.